Literature DB >> 15925652

Sarcoidosis.

Christopher E Cox1, Angela Davis-Allen, Marc A Judson.   

Abstract

Sarcoidosis is a disease found in most populations worldwide, although it has a proclivity for relatively young African-American women in the United States. Although the pathogenesis is unknown, there likely are social, environmental, and genetic factors that are involved. Sarcoidosis seems to be different between whites and African Americans, with the latter population experiencing more severe and chronic disease. Improving access to care and addressing other disparities in health care may help to bridge the gap in health outcomes observed between patients.

Entities:  

Mesh:

Year:  2005        PMID: 15925652     DOI: 10.1016/j.mcna.2005.02.006

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  10 in total

1.  Infliximab therapy for hepatic and intestinal sarcoidosis.

Authors:  Helen S Te; Lucas Campbell; Saima Chohan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-06

2.  Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis.

Authors:  Nam-Sihk Lee; Laura Barber; Ali Kanchwala; Carter J H Childs; Yash P Kataria; Marc A Judson; Mark A Mazer; Sergio Arce
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

3.  Association between sarcoidosis and cardiovascular Outcomes: A systematic review and Meta-analysis.

Authors:  Vikash Jaiswal; Song Peng Ang; Zouina Sarfraz; Swatika Butey; Harshwardhan Vinod Khandait; David Song; Jia Ee Chia; Dipansha Maroo; Muhammad Hanif; Mohammed Ghanim; Raja Chand; Monodeep Biswas
Journal:  Int J Cardiol Heart Vasc       Date:  2022-06-29

4.  Current clinical use of 18FDG-PET/CT in patients with thoracic and systemic sarcoidosis.

Authors:  Giuseppe Rubini; Salvatore Cappabianca; Corinna Altini; Antonio Notaristefano; Margherita Fanelli; Amato Antonio Stabile Ianora; Artor Niccoli Asabella; Antonio Rotondo
Journal:  Radiol Med       Date:  2013-11-15       Impact factor: 3.469

5.  Cardiac Involvement in Sarcoidosis Deaths in Wayne County, Michigan: A 20-Year Retrospective Study.

Authors:  Milad Webb; Kyle S Conway; Martin Ishikawa; Francisco Diaz
Journal:  Acad Forensic Pathol       Date:  2018-08-31

6.  Hydrocephalus with panventricular enlargement as the primary manifestation of neurosarcoidosis: a case report.

Authors:  Sadaharu Tabuchi; Tetsuji Uno
Journal:  J Med Case Rep       Date:  2013-10-14

7.  The prevalence of antinuclear antibodies in patients with sarcoidosis.

Authors:  Senol Kobak; Hatice Yilmaz; Fidan Sever; Arzu Duran; Nazime Sen; Ahmet Karaarslan
Journal:  Autoimmune Dis       Date:  2014-12-17

8.  Diagnostic Value and Effective Factors on Transbronchial Lung Biopsy Using Cup and Alligator Forceps.

Authors:  Alireza Eslaminejad; Arda Kiani; Negar Sheikhi; Makan Sadr; Zohreh Mohammad Taheri; Hamid Reza Jabardarjani
Journal:  Tanaffos       Date:  2016

9.  Hybrid Imaging in Head and Neck Sarcoidosis.

Authors:  Isidora Grozdic Milojevic; Marijana Tadic; Dragana Sobic-Saranovic; Jelena Saponjski; Vera M Artiko
Journal:  J Clin Med       Date:  2019-06-05       Impact factor: 4.241

10.  The importance of PET/CT findings and hematological parameters in prediction of progression in sarcoidosis cases.

Authors:  Can Tertemiz Kemal; Ozgen Alpaydin Aylin; Karacam Volkan; Mersin Seda; Bekis Recep; Sevinc Can
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.